Aug 29, 2019
MEI Pharma to Present at the 2019 Wells Fargo Healthcare Conference
Aug 28, 2019
MEI Pharma Reports Fiscal Year 2019 Results and Operational Highlights
Aug 21, 2019
MEI Pharma to Release 2019 Fiscal Year End Financial Results and Provide Corporate Update on August 28, 2019
Jul 03, 2019
MEI Pharma Appoints Longtime Industry Consultant and Executive Tamar Howson to its Board of Directors
Jun 03, 2019
MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study in Patients with Follicular Lymphoma at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 01, 2019
MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer Patients at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2019
MEI Pharma to Present at the Jefferies 2019 Global Healthcare Conference
May 09, 2019
MEI Pharma Reports Third Quarter Fiscal Year 2019 Results and Operational Highlights
Apr 02, 2019
MEI Pharma to Present at the 18th Annual Needham Healthcare Conference
Mar 12, 2019
MEI Pharma to Present at the 29th Annual Oppenheimer Healthcare Conference
Feb 07, 2019
MEI Pharma Reports Second Quarter Fiscal Year 2019 Results and Operational Highlights
Dec 03, 2018
Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting
Dec 02, 2018
MEI Pharma Presents Clinical Data from Ongoing Phase 1b Study of ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Hematology Annual Meeting
Nov 08, 2018
MEI Pharma Reports First Quarter Fiscal Year 2019 Results and Operational Highlights
Nov 06, 2018
MEI Pharma To Present at Stifel 2018 Healthcare Conference
Nov 05, 2018
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
Oct 11, 2018
MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies
Aug 30, 2018
MEI Pharma Reports Fiscal Year 2018 Results and Operational Highlights
Aug 29, 2018
MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference
Aug 23, 2018
MEI Pharma to Release 2018 Fiscal Year End Financial Results and Provide Corporate Update on August 30, 2018